THRB and primary cutaneous T-cell non-Hodgkin lymphoma: Molecular interrogation of TCR genes, TRG and TRB, has proven to be a critical tool for confirming diagnoses of CTCL and for disease tracking after initiation of therapy or after stem cell transplant.